The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 51.50
Bid: 51.40
Ask: 51.70
Change: -0.30 (-0.58%)
Spread: 0.30 (0.584%)
Open: 51.60
High: 52.10
Low: 51.30
Prev. Close: 51.80
IPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

21 Dec 2021 17:27

RNS Number : 4067W
IP Group PLC
21 December 2021
 

IP GROUP plc (the "Company")

 

Transaction in Own Shares

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group"), today announces that Numis Securities Limited purchased on behalf of IP Group the number of ordinary shares of 2 pence each on the London Stock Exchange as set out in the table below (the Repurchased Shares) pursuant to the IP Group share buyback programme announced on 8 October 2021 (the Buyback Programme).

Date of purchase:

21-Dec-21

Number of ordinary shares purchased:

200,000

Highest price paid per ordinary share (GBp):

120.60

Lowest price paid per ordinary share (GBp):

119.20

Volume weighted average price paid per ordinary share (GBp):

119.9212

The Group will hold the Repurchased Shares in treasury. Following the above transaction, the Group holds 21,954,127 of its ordinary shares in treasury and has 1,063,033,287 ordinary shares in issue (including treasury shares). Therefore, the total number of ordinary shares with voting rights will be 1,041,079,160 which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, IP Group under the FCA's Disclosure Guidance and Transparency Rules.

 

IP Group will make further announcements following the completion of any additional purchases pursuant to the Buyback Programme.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the purchases made by Numis Securities Limited on behalf of IP Group as part of the Buyback Programme.

 

Both aggregate data in respect of the Repurchased Shares as well as the individual purchases are set out below.

 

Aggregate information:

 

Issuer name and ISIN: IP Group plc (ISIN: GB00B128J450)

 

Date of purchases:

21 December 2021

Number of ordinary shares purchased:

200,000

Volume weighted average price (pence):

119.9212

Individual transactions:

 

Number of sharespurchased

Transaction price(per share)

Time of transaction

Trading venue

6206

120.40

 08:49:37

LSE

6234

120.40

 08:52:55

LSE

2600

120.20

 08:56:02

LSE

3515

120.20

 08:56:02

LSE

6044

120.20

 08:56:02

LSE

1166

119.80

 08:57:04

LSE

4299

119.80

 08:58:02

LSE

621

119.80

 08:58:02

LSE

3179

120.40

 09:26:24

LSE

2500

120.40

 09:41:07

LSE

1822

120.40

 09:41:07

LSE

1620

120.40

 09:41:07

LSE

45

120.20

 09:41:23

LSE

1

120.20

 09:41:29

LSE

2914

120.40

 09:47:21

LSE

3776

120.40

 09:47:21

LSE

1127

120.20

 10:00:14

LSE

2077

120.20

 10:01:31

LSE

3048

120.20

 10:01:31

LSE

1064

120.20

 10:01:31

LSE

5980

120.00

 10:06:36

LSE

127

120.60

 10:35:16

LSE

3149

120.60

 10:35:16

LSE

1464

120.60

 10:35:16

LSE

1670

120.60

 10:35:16

LSE

1438

120.40

 10:39:02

LSE

5200

120.40

 10:39:02

LSE

1219

120.40

 10:39:02

LSE

2079

120.20

 11:08:38

LSE

4324

120.20

 11:08:38

LSE

4213

120.00

 11:42:10

LSE

1864

120.00

 11:42:10

LSE

3322

120.00

 11:42:21

LSE

1460

120.00

 11:42:21

LSE

1006

120.00

 11:42:21

LSE

1

120.00

 11:42:21

LSE

1860

119.80

 12:07:00

LSE

4810

119.80

 12:07:00

LSE

397

119.80

 12:07:00

LSE

2062

119.60

 12:37:04

LSE

2600

119.60

 12:37:04

LSE

2374

119.60

 12:37:04

LSE

1437

119.40

 13:01:20

LSE

2600

119.40

 13:01:20

LSE

2005

119.40

 13:01:20

LSE

1299

119.20

 13:09:36

LSE

577

119.20

 13:09:36

LSE

4871

119.20

 13:09:36

LSE

6035

119.60

 13:47:26

LSE

3048

119.80

 14:20:35

LSE

3350

119.80

 14:20:35

LSE

1460

119.80

 14:20:35

LSE

5253

119.80

 14:20:35

LSE

1563

119.80

 14:20:35

LSE

1405

119.80

 14:20:35

LSE

2500

119.80

 14:21:35

LSE

308

120.20

 14:36:56

LSE

187

120.20

 14:38:57

LSE

2326

120.20

 14:38:57

LSE

228

120.20

 14:38:57

LSE

544

120.20

 14:38:57

LSE

611

120.20

 14:38:57

LSE

2387

120.20

 14:38:57

LSE

1638

120.20

 14:38:57

LSE

6073

120.20

 14:42:36

LSE

41

120.20

 14:42:36

LSE

2559

120.20

 14:42:36

LSE

1003

120.20

 14:42:36

LSE

5501

120.00

 14:46:24

LSE

1608

120.00

 14:46:24

LSE

4906

119.60

 15:23:52

LSE

1758

119.60

 15:23:52

LSE

2500

119.20

 15:37:48

LSE

839

119.20

 15:37:48

LSE

1460

119.20

 16:09:09

LSE

2600

119.20

 16:11:00

LSE

1210

119.20

 16:11:00

LSE

1246

119.20

 16:11:00

LSE

2077

119.20

 16:11:00

LSE

5200

119.20

 16:11:00

LSE

3008

119.20

 16:15:08

LSE

629

119.20

 16:15:08

LSE

2645

119.20

 16:15:08

LSE

1028

119.20

 16:15:08

LSE

 

 

 

For more information, please contact:

IP Group plc

www.ipgroupplc.com

Liz Vaughan-Adams, Communications

+44 (0) 20 7444 0062/+44 (0) 7979 853802

Charlotte Street Partners

David Gaffney

+44 (0) 7854 609998

Andrew Wilson

+44 (0) 7810 636995

 

Further information on IP Group is available on our website: www.ipgroupplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSZZMZZNMVGMZM
Date   Source Headline
12th Aug 20215:05 pmRNSDirector Declaration
5th Aug 20217:00 amRNSHalf-yearly results
27th Jul 20217:03 amRNSPortfolio company Artios Pharma raises $153m
22nd Jul 202111:30 amRNSNotice of Results
1st Jul 20217:00 amRNSTotal Voting Rights
28th Jun 20217:30 amRNSDirector/PDMR Shareholding
18th Jun 20219:52 amRNSDirector/PDMR Shareholding
17th Jun 20217:00 amRNSPortfolio company Apollo Therapeutics raises $145m
15th Jun 20218:00 amRNSFurther re Scrip Dividend
9th Jun 202111:29 amRNSResult of AGM
9th Jun 20217:00 amRNSAGM Statement
7th Jun 20217:00 amRNSPortfolio co Iksuda completes $42m financing round
28th May 20213:36 pmRNSDirector/PDMR Shareholding
28th May 202110:00 amRNSJoint venture with China Everbright to launch fund
27th May 20217:00 amRNSPortfolio co Pulmocide completes $92m Series C
26th May 20212:44 pmRNSUpdate on AGM
20th May 202110:01 amRNSScrip Dividend Reference Price
17th May 202112:44 pmRNSAdditional fair value gain of £20m
12th May 202112:08 pmRNSHolding(s) in Company
10th May 202111:15 amRNSInvestor webinars
6th May 20216:13 pmRNSNotice of AGM, Annual Report, Scrip Dividend
6th May 20215:55 pmRNSLTIP & DBSP awards; Director/PDMR shareholding
5th May 20217:00 amRNSPortfolio company Kuur acquired by Athenex
5th May 20217:00 amRNSPortfolio company Inivata acquired by NeoGenomics
4th May 20217:00 amRNSPortfolio company Oxford Nanopore raises £195m
7th Apr 202111:27 amRNSDirector/PDMR Shareholding
31st Mar 20219:15 amRNSHolding(s) in Company
30th Mar 20217:05 amRNSOxford Nanopore announces preparing for IPO in H2
26th Mar 202112:26 pmRNSEMA positive opinion for Diurnal's Chronocort
10th Mar 20217:00 amRNSAnnual Results
4th Mar 20216:07 pmRNSHolding(s) in Company
2nd Mar 202112:03 pmRNSHolding(s) in Company
24th Feb 202110:33 amRNSNotice of Results
18th Feb 20214:31 pmRNSHolding(s) in Company
18th Feb 20218:00 amRNSHolding(s) in Company
17th Feb 20217:00 amRNSPortfolio company ApcinteX acquired by Centessa
10th Feb 20217:00 amRNSIP Group, Inc. raises $50.0m (£36.5m*) of funding
9th Feb 20213:52 pmRNSHolding(s) in Company
2nd Feb 20215:15 pmRNSHolding(s) in Company
11th Jan 20215:29 pmRNSHolding(s) in Company
6th Jan 20214:57 pmRNSPortfolio co Hinge Health completes $300m round
6th Jan 202111:34 amRNSHolding(s) in Company
6th Jan 20217:00 amRNSPortfolio co Oxbotica completes £36m funding round
4th Dec 202011:41 amRNSHolding(s) in Company
3rd Dec 20208:01 amRNSArtios and Merck in global strategic collaboration
25th Nov 20207:00 amRNSDirector Declaration
23rd Nov 20205:05 pmRNSHolding(s) in Company
21st Oct 20207:00 amRNSInvestor webinar
13th Oct 20207:00 amRNSOxford Nanopore funding round and contract win
9th Oct 20209:46 amRNSOxford Nanopore's LamPORE test gains CE-IVD mark

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.